Claudio Sini

AOL (United States) — United States

Medicine · Health Sciences

18h-index743citations62works1.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(38), Lung Cancer Diagnosis and Treatment(15), Lung Cancer Research Studies(15), Cancer Genomics and Diagnostics(12), Colorectal Cancer Treatments and Studies(10)

Publications62 total

Braf-mutant metastatic non–small-cell lung cancer: Real world data from the Italian biomarker atlas database
European Journal of Cancer·2025Open Access
Bone metastases in NSCLC: Modern paradigms in management and supportive care
Cancer Treatment Reviews·2025Open Access
P3.12.15 Activity and Tolerability of MET Tkis in METex14 NSCLC: Updated Real-World Data From the Italian Biomarker Atlas Database
Journal of Thoracic Oncology·2025
Advanced-stage ALK-positive non–small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database
Lung Cancer·2025Open Access
2076eP From indication to therapeutic and prognostic impact: The role of molecular profiling in the management of advanced squamous NSCLC based on real-world data from the ATLAS Network
Annals of Oncology·2025
Narrative medicine in patients with cancer during intravenous antiblastic therapy: a qualitative study
Supportive Care in Cancer·2025
Real-world outcomes of subsequent treatment strategies after durvalumab consolidation in stage III unresectable non-small cell lung cancer
Lung Cancer·2025· 2 citedOpen Access
Current diagnostic and therapeutical approaches to bone metastases in patients with non-small cell lung cancer: A cross-sectional study
Lung Cancer·2025· 3 citedOpen Access
Advanced-Stage Alk-Positive Non–Small-Cell Lung Cancer (Nsclc) Patients: Real-World Treatment Patterns and Outcomes from the Italian Biomarker Atlas Database
SSRN Electronic Journal·2025Open Access
Braf-Mutant Metastatic Non–Small-Cell Lung Cancer: Real World Data from the Italian Biomarker Atlas Database
SSRN Electronic Journal·2025Open Access
Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA)
Journal of Thoracic Oncology·2024· 4 cited
Letter Re: Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations
European Journal of Cancer·2024· 1 cited
1283P Advanced ALK-positive non-small cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database
Annals of Oncology·2024· 2 citedOpen Access
1301P BRAF-mutant metastatic non-small cell lung cancer: Real-world data from the Italian biomarker ATLAS database
Annals of Oncology·2024· 3 citedOpen Access
MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database
ESMO Open·2024· 8 citedOpen Access
Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy
Current Oncology·2024· 8 citedOpen Access
Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients Treated with First Line Chemoimmunotherapy
Preprints.org·2024Open Access
53P MET exon 14 skipping mutations in non-small cell lung cancer: Real-world data from the Italian biomarker ATLAS database
ESMO Open·2024Open Access
Actionable Non-Small Cell Lung Cancer Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients with Advanced Lung Cancer (Epropa)
SSRN Electronic Journal·2024Open Access
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program
Lung Cancer·2023· 18 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Carlo Genova(31), Francesco Grossi(27), Maria Giovanna Dal Bello(25), Erika Rijavec(20), Giulia Barletta(16), Simona Coco(14), Angela Alama(12), Francesco Passiglia(12), Elisa Roca(12), P. Pronzato(10), Alessandro Russo(9), Diego Cortinovis(9), Giovanni Burrafato(9), Anna Truini(8), Federica Biello(8), Mauro Truini(8), Giuseppe Barletta(8), Gabriele Minuti(8), Fabrizio Citarella(7), Sara Pilotto(7)